News | PET-CT | March 06, 2019

Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT

Scanner installed at Hospital of the University of Pennsylvania (HUP) in Philadelphia

Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT

March 5, 2019 — Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been installed at the Hospital of the University of Pennsylvania (HUP) in Philadelphia – the first healthcare institution in the United States to install the technology.

The Biograph Vision possesses new Optiso UDR detector technology that is based on 3.2 x 3.2 mm lutetium oxyorthosilicate (LSO) crystal elements and digital silicon photomultipliers (SiPMs). With this technology, the system delivers higher spatial resolution while achieving what Siemens calls the industry’s fastest time-of-flight, with a temporal resolution of 214 picoseconds, as well as an effective sensitivity of 100 cps/kBq. For these reasons, the Biograph Vision helps to reduce scan time to as low as 3 minutes per patient to improve throughput, reduce patient radiation exposure and cut tracer cost. The 78-cm bore aids in patient positioning and can help ensure patient comfort.

The Biograph Vision also has optional features aimed at improving patient care. OncoFreeze provides PET/CT images that are virtually free of motion in the same period as a regular whole-body scan. CardioFreeze takes cardiac gating one step further, incorporating OncoFreeze technology to correct respiratory motion in the heart. FlowMotion Multiparametric Suite delivers images of standard uptake volume (SUV), metabolic glucose rate, and distribution volume.

For more information: www.usa.healthcare.siemens.com

Related Content

News | Nuclear Imaging

April 13, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear ...

Home April 13, 2022
Home
Videos | Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D., MASNC, FASE, FSCCT, director of cardiac ...

Home February 01, 2022
Home
Feature | Nuclear Imaging | By Staff of the American Society of Nuclear Cardiology (ASNC)

A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...

Home June 02, 2021
Home
News | Nuclear Imaging

April 1, 2021 – The ability to measure myocardial blood flow (MBF) as part of myocardial perfusion imaging (MPI) is one ...

Home April 01, 2021
Home
News | Nuclear Imaging

December 4, 2020 — Spectrum Dynamics Medical, Inc., has received Canadian Medical Device License from Health Canada for ...

Home December 04, 2020
Home
News | Nuclear Imaging

September 30, 2020 — Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine ...

Home October 07, 2020
Home
Feature | Nuclear Imaging | Dave Fornell, Editor

There were a few key takeaways from the American Society of Nuclear Cardiology (ASNC) 2019 annual meeting in September ...

Home November 22, 2019
Home
Videos | Nuclear Imaging

Rob Beanlands, M.D., FASNC, 2019 American Society of Nuclear Cardiology (ASNC) president, shares a couple trends he sees ...

Home November 07, 2019
Home
Videos | Nuclear Imaging

Robert C. Hendel, M.D., explains some of the new cardiac radiotracers in the pipeline that were discussed in sessions at ...

Home November 06, 2019
Home
Feature | Nuclear Imaging | Christopher A. Hanson M.D., and Jamieson M. Bourque M.D., MHS

Cardiac amyloidosis is a highly morbid and underdiagnosed infiltrative cardiomyopathy that is characterized by the ...

Home July 22, 2019
Home
Subscribe Now